Heron Therapeutics (HRTX) – Analyst Ratings
-
CapitalOne Starts Heron Therapeutics (HRTX) at Overweight
-
Heron Therapeutics (HRTX) PT Raised to $5 at Needham to reflect strong sales trends
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to HRTX Stock Lookup